U.S. blocks Chinese genomics giants BGI, BGI Genomics, and MGI Tech over forced labor ties

U.S. blocks Chinese genomics giants over forced labor allegations

The Trump administration has ordered U.S. Customs and Border Protection to block shipments from BGI Group — one of the world's largest genetic sequencing companies — along with its subsidiaries BGI Genomics and MGI Tech. The Department of Homeland Security (DHS) cited credible evidence that the companies are sourcing materials from China's Xinjiang region or actively facilitating forced labor of persecuted ethnic minorities, including Uyghurs.

The ban falls under the Uyghur Forced Labor Prevention Act, signed into law in 2021, and comes as biotechnology emerges as a new front in the broader U.S.-China economic and tech rivalry. The Treasury Department also recently proposed new restrictions on U.S. investments flowing into Chinese biotech, AI, and supercomputing sectors.

Key Takeaways:

• All three companies — BGI Group, BGI Genomics, and MGI Tech — have been designated as Chinese military companies by the Pentagon
• BGI Group has long been scrutinized by U.S. lawmakers over its alleged ties to the Chinese government and access to large-scale genetic data
• China's Ministry of Commerce rejected the allegations and warned of "necessary measures" to protect its interests

Why it matters: BGI's genetic sequencing technologies are globally influential, and this ban signals that genomics and biotech are now firmly in the crosshairs of U.S.-China geopolitical competition — with potential ripple effects for research, supply chains, and data security worldwide.